RUISHUN BIO
Ruishun Bio was established in February 2012, focusing on the development of off-the-shelf universal DNT immune cells. A complete cell production, preparation, and quality control system has been established, and the pipeline for relapsed and refractory acute myeloid leukemia has entered clinical phase I, making it the world's first non-gene editing general-purpose tumor immune cell product . The company will further expand the indication scope of DNT cells on the basis of continuous optimization of the existing process, so as to solve the unmet clinical needs with better efficacy.
RUISHUN BIO
Industry:
Biopharma Biotechnology Life Science
Founded:
2012-02-01
Status:
Active
Total Funding:
8.7 M USD
Investors List
Baidu Ventures
Baidu Ventures investment in Series A - Ruishun Bio
Huaxia Heng Tian
Huaxia Heng Tian investment in Venture Round - Ruishun Bio
More informations about "Ruishun Bio"
Ruishun Bio - Crunchbase Company Profile & Funding
Ruishun Bio is a complete cell production, preparation, and quality control system. Ruishun Bio was established in February 2012, focusing on the development of off-the-shelf universal DNT โฆSee details»
Ruishun Biotechnology | VentureRadar
Established in February 2012, Ruishun Bio is a Sino-foreign joint venture biopharmaceutical company focusing on the development of a series of global innovative immune cell drugs for โฆSee details»
Ruishun Bio - Funding, Financials, Valuation & Investors
Ruishun Bio is a complete cell production, preparation, and quality control system.See details»
BV Familyไธจ Ruishun Biotechnology has completed 100 million โฆ
Sep 17, 2021ย ยท Recently, Guangdong Ruishun Biotechnology Co., Ltd. (referred to as "Ruishun Bio" or "Company"), the global leader in spot universal DNT cell drugs, announced the โฆSee details»
Ruishun Bio - Drug pipelines, Patents, Clinical trials - Synapse
Explore Ruishun Bio with its drug pipeline, therapeutic area, technology platform, .See details»
Ruishun Bio - Company Profile - Tracxn
Ruishun Bio - Developer of cell therapies for cancer treatment. Raised a total funding of $8.69M over 1 round from 2 investors. Ruishun Bio has 2827 competitors.See details»
Ruishun Bio - Raised $8.69M Funding from 2 investors - Tracxn
Ruishun Bio has raised a total funding of $8.69M over 1 round from 2 investors. Investors include Baidu Ventures and Yuecai Pharmaceutical Fund. Their latest funding round was of $8.69M โฆSee details»
Ruishun Bio - Crunchbase
Ruishun Bio is a complete cell production, preparation, and quality control system.See details»
Ruichuang Biologics was approved for IND for the new ... - ECHEMI
Jan 6, 2023ย ยท Guangdong Ruishun Biotechnology Co. , Ltd. takes "caring for life and benefiting mankind" and "being an affordable innovative cell drug" as its own responsibility, focusing on โฆSee details»
Ruishun Bio: The first allogeneic DNT cell drug in China to
Jan 22, 2021ย ยท Ruishun Bio focuses on the development of DNT cells as the core technology platform of non-gene editing spot universal immune cell product line, the company is currently โฆSee details»
Zhejiang Ruishun Biological Technology Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zhejiang Ruishun Biological Technology Co., Ltd. of Hangzhou, Zhejiang. Get the latest business โฆSee details»
Ruishun Biotechnology - VentureRadar
Established in February 2012, Ruishun Bio is a Sino-foreign joint venture biopharmaceutical company focusing on the development of a series of global innovative immune cell drugs for โฆSee details»
Ruishun Bio - Updates, News, Events, Signals & Triggers
Ruishun Bio is a complete cell production, preparation, and quality control system.See details»
"Ruishun biology" completed round a financing of RMB 137 million
Oct 22, 2021ย ยท Spot general DNT cell drug company "Ruishun biology" has recently completed a round of financing of RMB 137 million. This round of financing is led by Fuhui venture capital โฆSee details»
Peptide Biotechnology - Crunchbase
Ruishun Bio is a complete cell production, preparation, and quality control system. Pharma startup with connections to superlative expertise and laboratories. Peptide Biotech is a peptide โฆSee details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
What Are The Levels Of Organization In Biology? | Sciencing
Oct 7, 2019ย ยท Biology is the study of life. Since life is such a broad topic, scientists break it down into several different levels of organization to make it easier to study. These levels start from โฆSee details»
List of Ruishun Bio's 2 Funding Rounds totaling CNยฅ59M
Funding Round search resultsSee details»
Series A - Ruishun Bio - 2022-08-17 - Crunchbase
Aug 17, 2022ย ยท Organization Name . Ruishun Bio . Announced Date Aug 17, 2022; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . obfuscated. obfuscated. Lead โฆSee details»